SIGHT SCIENCES INC (SGHT) competitors & alternatives
Health Care · NASDAQ
SIGHT SCIENCES INC (SGHT)'s top competitors and alternatives — its most similar public companies — include Johnson & Johnson (JNJ), GLAUKOS CORP (GKOS), Cooper Companies (The) (COO), Boston Scientific (BSX), Abbott Laboratories (ABT), Medtronic (MDT), Microbot Medical Inc. (MBOT), Penumbra, Inc. (PEN), UFP TECHNOLOGIES INC (UFPT), Fractyl Health, Inc. (GUTS), CONMED CORP (CNMD) and LENZ THERAPEUTICS INC (LENZ). These are SIGHT SCIENCES INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top SGHT competitors & alternatives
-
Johnson & JohnsonJNJHealth Care
A global healthcare leader spanning pharmaceuticals, medical devices, and consumer health products, with a portfolio spanning acute care, oncology, immunology,…
$255.63 (as of 2026-07-22) · market cap $614.6B
-
GLAUKOS CORPGKOSHealth Care
Glaukos is a specialized ophthalmic company transforming eye care through innovative Micro-Invasive Glaucoma Surgery devices and proprietary sustained-release…
$152.86 (as of 2026-07-22) · market cap $8.9B
-
Cooper Companies (The)COOHealth Care
A global medical device leader operating at the intersection of vision care and women's health through its CooperVision and CooperSurgical divisions.
$70.50 (as of 2026-07-22) · market cap $13.9B
-
Boston ScientificBSXHealth Care
Boston Scientific is a leading medical technology company delivering minimally invasive interventional solutions to improve patient health across diverse…
$42.97 (as of 2026-07-22) · market cap $63.7B
-
Abbott LaboratoriesABTHealth Care
Abbott Laboratories is a diversified healthcare giant providing a broad portfolio of diagnostic systems, medical devices, nutritional products, and established…
$100.57 (as of 2026-07-22) · market cap $175.1B
-
MedtronicMDTHealth Care
Global medical device leader deploying pacemakers, defibrillators, spinal implants, surgical robotics, and diabetes management systems to alleviate pain,…
$81.89 (as of 2026-07-22) · market cap $105.1B
-
Microbot Medical Inc.MBOTHealth Care
Microbot Medical is an early-stage medical device company developing next-generation robotic endoluminal surgical systems for minimally invasive interventional…
$1.77 (as of 2026-07-22) · market cap $119M
-
Penumbra, Inc.PENHealth Care
The world's leading mechanical thrombectomy company enabling rapid, minimally invasive blood clot removal across ischemic stroke, pulmonary embolism, and limb…
$316.50 (as of 2026-07-22) · market cap $12.4B
-
UFP TECHNOLOGIES INCUFPTHealth Care
A specialized contract manufacturer producing custom single-use and single-patient medical devices for major OEMs across minimally invasive surgery, wound…
$237.96 (as of 2026-07-22) · market cap $1.9B
-
Fractyl Health, Inc.GUTSHealth Care
Fractyl Health is a clinical-stage medical device and gene therapy company developing the Revita mucosa resurfacing procedure and Rejuva gene therapy platform…
$0.76 (as of 2026-07-22) · market cap $123M
-
CONMED CORPCNMDHealth Care
CONMED makes surgical visualization, insufflation, and monitoring devices that enable surgeons to perform minimally invasive procedures more effectively and…
$42.00 (as of 2026-07-22) · market cap $1.3B
-
LENZ THERAPEUTICS INCLENZHealth Care
LENZ Therapeutics is a commercial-stage ophthalmic company that developed VIZZ, the first FDA-approved, once-daily aceclidine-based eye drop for the treatment…
$5.34 (as of 2026-07-22) · market cap $167M
Not quite? Describe exactly what you want →
Peers are SIGHT SCIENCES INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: SIGHT SCIENCES INC (SGHT).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.